460 related articles for article (PubMed ID: 31473800)
21. Optimized image acquisition for dopamine transporter imaging with ultra-high resolution clinical pinhole SPECT.
Chen Y; Vastenhouw B; Wu C; Goorden MC; Beekman FJ
Phys Med Biol; 2018 Nov; 63(22):225002. PubMed ID: 30403197
[TBL] [Abstract][Full Text] [Related]
22. Stereotactical normalization with multiple templates representative of normal and Parkinson-typical reduction of striatal uptake improves the discriminative power of automatic semi-quantitative analysis in dopamine transporter SPECT.
Apostolova I; Schiebler T; Lange C; Mathies FL; Lehnert W; Klutmann S; Buchert R
EJNMMI Phys; 2023 Mar; 10(1):25. PubMed ID: 36991245
[TBL] [Abstract][Full Text] [Related]
23. Iodine-123-N-omega-fluoropropyl-2beta-carbomethoxy-3beta-(4-iod ophenyl)tropane SPECT in healthy controls and early-stage, drug-naive Parkinson's disease.
Tissingh G; Booij J; Bergmans P; Winogrodzka A; Janssen AG; van Royen EA; Stoof JC; Wolters EC
J Nucl Med; 1998 Jul; 39(7):1143-8. PubMed ID: 9669384
[TBL] [Abstract][Full Text] [Related]
24. Global scaling for semi-quantitative analysis in FP-CIT SPECT.
Kupitz D; Apostolova I; Lange C; Ulrich G; Amthauer H; Brenner W; Buchert R
Nuklearmedizin; 2014; 53(6):234-41. PubMed ID: 25209576
[TBL] [Abstract][Full Text] [Related]
25. Computer-aided diagnosis of Parkinson's disease based on [(123)I]FP-CIT SPECT binding potential images, using the voxels-as-features approach and support vector machines.
Oliveira FP; Castelo-Branco M
J Neural Eng; 2015 Apr; 12(2):026008. PubMed ID: 25710187
[TBL] [Abstract][Full Text] [Related]
26. Application of texture analysis to DAT SPECT imaging: Relationship to clinical assessments.
Rahmim A; Salimpour Y; Jain S; Blinder SA; Klyuzhin IS; Smith GS; Mari Z; Sossi V
Neuroimage Clin; 2016; 12():e1-e9. PubMed ID: 27995072
[TBL] [Abstract][Full Text] [Related]
27. Right putamen and age are the most discriminant features to diagnose Parkinson's disease by using
Cascianelli S; Tranfaglia C; Fravolini ML; Bianconi F; Minestrini M; Nuvoli S; Tambasco N; Dottorini ME; Palumbo B
Hell J Nucl Med; 2017; 20 Suppl():165. PubMed ID: 29324935
[TBL] [Abstract][Full Text] [Related]
28. A convolutional neural network algorithm for automatic segmentation of head and neck organs at risk using deep lifelong learning.
Chan JW; Kearney V; Haaf S; Wu S; Bogdanov M; Reddick M; Dixit N; Sudhyadhom A; Chen J; Yom SS; Solberg TD
Med Phys; 2019 May; 46(5):2204-2213. PubMed ID: 30887523
[TBL] [Abstract][Full Text] [Related]
29. Use of 11C-PE2I PET in differential diagnosis of parkinsonian disorders.
Appel L; Jonasson M; Danfors T; Nyholm D; Askmark H; Lubberink M; Sörensen J
J Nucl Med; 2015 Feb; 56(2):234-42. PubMed ID: 25593112
[TBL] [Abstract][Full Text] [Related]
30. No impact of attenuation and scatter correction on the interpretation of dopamine transporter SPECT in patients with clinically uncertain parkinsonian syndrome.
Schiebler T; Apostolova I; Mathies FL; Lange C; Klutmann S; Buchert R
Eur J Nucl Med Mol Imaging; 2023 Sep; 50(11):3302-3312. PubMed ID: 37328621
[TBL] [Abstract][Full Text] [Related]
31. Convolutional Neural Networks for Neuroimaging in Parkinson's Disease: Is Preprocessing Needed?
Martinez-Murcia FJ; Górriz JM; Ramírez J; Ortiz A
Int J Neural Syst; 2018 Dec; 28(10):1850035. PubMed ID: 30215285
[TBL] [Abstract][Full Text] [Related]
32. Improvement in the measurement error of the specific binding ratio in dopamine transporter SPECT imaging due to exclusion of the cerebrospinal fluid fraction using the threshold of voxel RI count.
Mizumura S; Nishikawa K; Murata A; Yoshimura K; Ishii N; Kokubo T; Morooka M; Kajiyama A; Terahara A
Ann Nucl Med; 2018 May; 32(4):288-296. PubMed ID: 29546633
[TBL] [Abstract][Full Text] [Related]
33. Extraction, selection and comparison of features for an effective automated computer-aided diagnosis of Parkinson's disease based on [
Oliveira FPM; Faria DB; Costa DC; Castelo-Branco M; Tavares JMRS
Eur J Nucl Med Mol Imaging; 2018 Jun; 45(6):1052-1062. PubMed ID: 29275487
[TBL] [Abstract][Full Text] [Related]
34. Validation of a standardized normalization template for statistical parametric mapping analysis of 123I-FP-CIT images.
Kas A; Payoux P; Habert MO; Malek Z; Cointepas Y; El Fakhri G; Chaumet-Riffaud P; Itti E; Remy P
J Nucl Med; 2007 Sep; 48(9):1459-67. PubMed ID: 17704252
[TBL] [Abstract][Full Text] [Related]
35. Iodine-123-beta-CIT and iodine-123-FPCIT SPECT measurement of dopamine transporters in healthy subjects and Parkinson's patients.
Seibyl JP; Marek K; Sheff K; Zoghbi S; Baldwin RM; Charney DS; van Dyck CH; Innis RB
J Nucl Med; 1998 Sep; 39(9):1500-8. PubMed ID: 9744331
[TBL] [Abstract][Full Text] [Related]
36. Improved visual [(123)I]FP-CIT SPECT interpretation for evaluation of parkinsonism by visual rating of parametric distribution volume ratio images.
Meyer PT; Winz OH; Dafotakis M; Werner CJ; Krohn T; Schäfer WM
Q J Nucl Med Mol Imaging; 2011 Jun; 55(3):301-9. PubMed ID: 21532542
[TBL] [Abstract][Full Text] [Related]
37. Chronic motor cortex stimulation in patients with advanced Parkinson's disease and effects on striatal dopaminergic transmission as assessed by 123I-FP-CIT SPECT: a preliminary report.
Di Giuda D; Calcagni ML; Totaro M; Cocciolillo F; Piano C; Soleti F; Fasano A; Cioni B; Bentivoglio AR; Giordano A
Nucl Med Commun; 2012 Sep; 33(9):933-40. PubMed ID: 22735298
[TBL] [Abstract][Full Text] [Related]
38. Creation and validation of an I-123 FP-CIT template for statistical image analysis using high-resolution SPECT for parkinsonian patients.
Hida K; Nonokuma M; Kuwabara Y; Tani T; Takano K; Yoshimitsu K
Ann Nucl Med; 2016 Aug; 30(7):477-83. PubMed ID: 27225162
[TBL] [Abstract][Full Text] [Related]
39. Utility of Follow-up Dopamine Transporter SPECT With 123I-FP-CIT in the Diagnostic Workup of Patients With Clinically Uncertain Parkinsonian Syndrome.
Apostolova I; Taleb DS; Lipp A; Galazky I; Kupitz D; Lange C; Makowski MR; Brenner W; Amthauer H; Plotkin M; Buchert R
Clin Nucl Med; 2017 Aug; 42(8):589-594. PubMed ID: 28574876
[TBL] [Abstract][Full Text] [Related]
40. Age-related effects and gender differences in Japanese healthy controls for [
Yamamoto H; Arimura S; Nakanishi A; Shimo Y; Motoi Y; Ishiguro K; Murakami K; Hattori N; Aoki S
Ann Nucl Med; 2017 Jun; 31(5):407-412. PubMed ID: 28382589
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
